Axsome Therapeutics (AXSM) Treasury Shares (2020 - 2026)
Axsome Therapeutics recorded quarterly Treasury Shares of $1.3 million in Q1 2026, up 29.13% quarter-over-quarter from $1.0 million in Q4 2025, and up 1934.51% year-over-year from $64281.0 in Q1 2025.
Axsome Therapeutics' Treasury Shares history runs 7 years deep, the most recent figure standing at $1.3 million for Q1 2026.
- In Q1 2026, Treasury Shares rose 1934.51% year-over-year to $1.3 million; the TTM figure through Mar 2026 stood at $1.3 million (up 1934.51% YoY), while the FY2025 annual figure was $1.0 million, up 11.67% from the prior year.
- Treasury Shares came in at $1.3 million for Q1 2026 at Axsome Therapeutics, up from $1.0 million in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $1.3 million in Q1 2026 to a low of $64281.0 in Q1 2025.
- A 5-year average of $709155.5 and a median of $787134.0 in 2023 frame the typical range for Treasury Shares.
- Across the five-year window, Treasury Shares slumped 93.03% in 2025 and jumped 1934.51% in 2026, its largest moves.
- Axsome Therapeutics' Treasury Shares stood at $686375.0 in 2022, then rose by 17.16% to $804150.0 in 2023, then gained by 12.78% to $906944.0 in 2024, then advanced by 11.67% to $1.0 million in 2025, then grew by 29.13% to $1.3 million in 2026.
- According to Business Quant data, Treasury Shares over the past three periods registered $1.3 million, $1.0 million, and $64281.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 265,401.92 |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 700,000.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 34.70 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Axsome Therapeutics | 11.82 Bn | 11.51 Bn | 176.48 Mn | 1.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.31 Mn |
| Mar 31, 2026 | 1.31 Mn |
| Dec 31, 2025 | 1.01 Mn |
| Dec 31, 2025 | 1.01 Mn |
| Sep 30, 2025 | 64,281.00 |
| Sep 30, 2025 | 64,281.00 |
| Jun 30, 2025 | 64,281.00 |
| Jun 30, 2025 | 64,281.00 |
| Mar 31, 2025 | 64,281.00 |
| Mar 31, 2025 | 64,281.00 |
| Dec 31, 2024 | 906,944.00 |
| Dec 31, 2024 | 906,944.00 |
| Sep 30, 2024 | 899,277.00 |
| Sep 30, 2024 | 899,277.00 |
| Jun 30, 2024 | 893,055.00 |
| Jun 30, 2024 | 893,055.00 |
| Mar 31, 2024 | 922,651.00 |
| Mar 31, 2024 | 922,651.00 |
| Dec 31, 2023 | 804,150.00 |
| Dec 31, 2023 | 804,150.00 |
| Sep 30, 2023 | 798,286.00 |
| Sep 30, 2023 | 798,286.00 |
| Jun 30, 2023 | 776,708.00 |
| Jun 30, 2023 | 776,708.00 |
| Mar 31, 2023 | 787,134.00 |
| Mar 31, 2023 | 787,134.00 |
| Dec 31, 2022 | 686,375.00 |
| Dec 31, 2022 | 686,375.00 |
| Sep 30, 2022 | 686,933.00 |
| Sep 30, 2022 | 686,933.00 |
| Jun 30, 2022 | 713,311.00 |
| Jun 30, 2022 | 713,311.00 |
| Mar 31, 2022 | 667,366.00 |
| Mar 31, 2022 | 667,366.00 |
| Dec 31, 2021 | 302,764.00 |
| Dec 31, 2021 | 302,764.00 |
| Sep 30, 2021 | 302,001.00 |
| Sep 30, 2021 | 302,001.00 |
| Jun 30, 2021 | 309,126.00 |
| Jun 30, 2021 | 309,126.00 |
| Mar 31, 2021 | 303,983.00 |
| Mar 31, 2021 | 303,983.00 |
| Dec 31, 2020 | 136,067.00 |
| Dec 31, 2020 | 136,067.00 |
| Sep 30, 2020 | 155,922.00 |
| Sep 30, 2020 | 155,922.00 |
| Jun 30, 2020 | 150,143.00 |
| Jun 30, 2020 | 150,143.00 |
| Mar 31, 2020 | 149,389.00 |
| Mar 31, 2020 | 149,389.00 |